子午流注序贯穴位埋线治疗HBeAg阴性乙肝病毒携带者外周血T细胞亚群变化的临床观察  

Changes of T cell subsets of HBV carriers with negative HBeAg treated by midnight-midday ebb flow sequential catguting embedment in acupoint

作　　者：殷小兰[1] 侯秋科[1] 

机构地区：[1]柳州市中医院消化科,广西柳州545001

出　　处：《中西医结合肝病杂志》2013年第1期17-18,共2页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases

基　　金：广西壮族自治区卫生厅中医药专项课题(No.GZKZ10-090)

摘　　要：目的:观察子午流注序贯穴位埋线治疗HBeAg阴性乙肝病毒携带者外周血T细胞亚群的变化。方法:将120例HBeAg阴性乙肝病毒携带者随机分为治疗组60例和对照组60例,治疗组予子午流注序贯穴位埋线治疗,疗程3个月;对照组给予口服胸腺肽肠溶片治疗,疗程3个月。采用流式细胞仪检测T细胞亚群的变化情况。结果:两组相比,血CD4+T细胞、CD8+T细胞百分比及CD4+T/CD8+T较治疗前明显增加,差异均有统计学意义(P<0.05)。结论:子午流注序贯穴位埋线治疗HBeAg阴性乙肝病毒携带者,可以有效改善患者细胞免疫功能状态,提高临床疗效。Objective： To investigate the changes of T cell subsets of patients with negative HBeAg treated by midnight- midday ebb flow sequential catguting embedment in acupoint. Methods： One hundred-twenty cases of chronic hepatitis B without HBeAg were divided into two groups randomly： the therapeutic group - midnight-midday ebb flow sequential catguting embedment in acupoint （once a week） and the control group -thymopeptides enteric-coated tablets, three monthes as a period of treatment. Results： The percentage of CD4 ^＋ T cells, CD8 ^＋ T in peripheral blood of therapeutic group were significantly increased （ P 〈 0. 05） . Conclusion： Midnight-midday ebb flow sequential catguting embedment in acupoint can improve T lymphocyte subsets imbalances and cellular immune of the chronic hepatitis B without HBeAg.

关 键 词：子午流注 穴位埋线 乙型肝炎病毒 T细胞亚群 

分 类 号：R512.62[医药卫生—内科学]